All In Biotech

Free tool

FAERS Monitor: Calcium Chloride 10% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021117 or its brand name (Calcium Chloride 10% In Plastic Container, Calcium Chloride). Reports on generic versions are filed under their own applications.

Reports

3,113

Serious

2,812

90% of reports

Hospitalization

1,413

Death reported

734

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain434
  • drug ineffective425
  • injury414
  • nausea358
  • off label use336
  • anxiety295
  • renal failure276
  • pyrexia274
  • dyspnoea254
  • hypotension251
  • condition aggravated242
  • pemphigus230
  • oedema226
  • vomiting224
  • pneumonia223

Reports by year received

View as table
YearReports
200414
200511
200631
2007584
200830
200921
201046
2011240
201284
201332
201468
201541
201653
201786
2018137
2019135
2020162
2021159
2022190
2023246
2024315
2025249
2026179

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,046 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal230126.6111.728,030
injurySignal41440.036.615,670
oedemaSignal22628.324.95,908
renal failureSignal27614.112.63,352
hypotensionSignal2518.57.51,658
anxietySignal2957.06.31,533
condition aggravatedSignal2425.44.8871
pyrexiaSignal2745.44.8981
painSignal4344.84.41,330
pneumoniaSignal2234.74.1646
vomitingSignal2243.22.8348
nauseaSignal3583.12.8513
dyspnoeaSignal2543.02.7353
off label useSignal3362.62.3341
drug ineffectiveSignal4252.22.0288

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.